376.80
-0.11%
Close of 9 Nov 2026, in DKK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Demant A/S
Its shares trade on Nasdaq Copenhagen under the ticker DEMANT.CO. It has been listed since 1 May 1995. In the fiscal year to 31 December 2025, it reported revenue of DKK 23.08bn and net income of DKK 1.54bn. At that date it held total assets of DKK 39.07bn and shareholders' equity of DKK 9.84bn.
Demant A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 1 May 1995
- Employees
- 15,352
- Website
- demant.com ↗
Leadership
Pay as last reported
- Mr. Niels ChristiansenChairman of the BoardDKK 1.4m
- Mr. Soeren NielsenPresident, Chief Executive Officer, Member of the Executive BoardDKK 16.5m
- Mr. Niels JacobsenVice Chairman of the BoardDKK 1.0m
- Mr. Rene SchneiderChief Financial Officer, Member of the Executive BoardDKK 8.9m
- Ms. Anne-karen HuntPresident - Diagnostics, Member of the Executive Board
- Mr. Niels WagnerPresident - Hearing Care, Member of the Executive Board, since 2022DKK 6.9m
- Mr. Thomas DuerDirector, Staff-ElectedDKK 450,000
- Ms. Heidir HoerbyDirector, Staff-ElectedDKK 450,000
- Mr. Anders ThomsenDirector, Staff-ElectedDKK 113,000
- Ms. Katrin PucknatIndependent Director
- Ms. Sisse RasmussenIndependent DirectorDKK 650,000
- Mr. Kristian VillumsenIndependent DirectorDKK 550,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 78
- Environment
- 92
- Social
- 97
- Governance
- 44
- Direct emissions (scope 1)
- 14,904 t
- Energy emissions (scope 2)
- 18,419 t
- Value chain emissions (scope 3)
- 492,026 t
- Women in the workforce
- 64.38545%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Demant A/S has several strengths that contribute to its success in the market. Firstly, the company has a strong brand reputation and is recognized as a leading provider of hearing healthcare solutions. This brand recognition helps to attract and retain customers.
- Secondly, Demant A/S has a diverse portfolio of products and services, ranging from hearing aids to diagnostic equipment. This diversification allows the company to cater to various customer needs and strengthens its position in the market.
- Additionally, Demant A/S has a dedicated research and development team that consistently innovates and introduces new technologies. This commitment to R&D enables the company to stay ahead of competitors and offer cutting-edge solutions to customers.
Weaknesses
- Despite its strengths, Demant A/S also faces certain weaknesses. One of the key weaknesses is the high cost associated with its products and services. The premium pricing strategy may limit the company's potential customer base, especially in price-sensitive markets.
- Furthermore, Demant A/S heavily relies on third-party suppliers for components and materials. This dependency makes the company vulnerable to supply chain disruptions, which could impact its ability to meet customer demands and maintain production levels.
Opportunities
- Demant A/S operates in a growing market, where the demand for hearing healthcare solutions is increasing. The aging population and greater awareness of hearing health provide substantial growth opportunities for the company.
- Additionally, the advancement of digital technologies opens doors for new product development and innovative solutions. Demant A/S can leverage this opportunity to expand its product line and cater to the evolving needs of customers.
Threats
- There are several external factors that pose threats to Demant A/S. One significant threat is intense competition from both established players and new entrants in the industry. This competitive landscape may put pressure on the company's market share and profitability.
- Another threat is the regulatory environment, which often undergoes changes and requires compliance. Adapting to new regulations and ensuring compliance can be challenging and may impact Demant A/S's operations and financial performance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.